Literature DB >> 1403550

Severe tracheomalacia associated with esophageal atresia: results of surgical treatment.

R M Filler1, A Messineo, I Vinograd.   

Abstract

This study reviews our experience from 1977 to 1991 with 32 children born with esophageal atresia and tracheoesophageal fistula (EA-TEF) who later underwent surgery for severe tracheomalacia. Indications for surgery included dying spells (21), inability to extubate the airway (nasotracheal tube 5, tracheotomy 3), and recurrent pneumonia (3). Diagnosis was confirmed by chest x-ray, esophagogram, and bronchoscopy. Aortopexy was performed in 31 of 32 children; a splint without aortopexy was used in one older girl. Splinting was also necessary in two of the 31 at the initial operation, when aortopexy failed to prevent tracheal collapse. There were four initial failures. Currently, 29 children are well (median follow-up, 6.6 years). Two have a tracheostomy in place, and one, who had a vascular ring divided after aortopexy, died at home of unknown cause 1 month later. These findings indicate that aortopexy provides long-term relief of severe symptoms of tracheomalacia associated with EA-TEF in almost all affected children. When aortopexy fails, the insertion of an airway splint may succeed; otherwise, tracheostomy is necessary.

Entities:  

Mesh:

Year:  1992        PMID: 1403550     DOI: 10.1016/0022-3468(92)90575-r

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

Review 1.  Adult outcome of congenital lower respiratory tract malformations.

Authors:  M S Zach; E Eber
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

2.  3D-printed, externally-implanted, bioresorbable airway splints for severe tracheobronchomalacia.

Authors:  Andrea S Les; Richard G Ohye; Amy G Filbrun; Maryam Ghadimi Mahani; Colleen L Flanagan; Rodney C Daniels; Kelley M Kidwell; David A Zopf; Scott J Hollister; Glenn E Green
Journal:  Laryngoscope       Date:  2019-02-22       Impact factor: 3.325

3.  Factors of family impact in a Swedish-German cohort of children born with esophageal atresia.

Authors:  John E Chaplin; Julia H Quitmann; Michaela Dellenmark-Blom; Kate Abrahamsson; Jens Dingemann; Stefanie Witt; Carmen Dingemann; Linus Jönsson; Vladimir Gatzinsky; Monika Bullinger; Benno M Ure
Journal:  Orphanet J Rare Dis       Date:  2022-05-21       Impact factor: 4.303

4.  Aortopexy in infants and children--long-term follow-up in twenty patients.

Authors:  Ulf Abdel-Rahman; Andreas Simon; Peter Ahrens; Klaus Heller; Anton Moritz; Hans-Gerd Fieguth
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

Review 5.  Oesophageal atresia.

Authors:  Lewis Spitz
Journal:  Orphanet J Rare Dis       Date:  2007-05-11       Impact factor: 4.123

Review 6.  Respiratory Morbidity in Children with Repaired Congenital Esophageal Atresia with or without Tracheoesophageal Fistula.

Authors:  Maria Francesca Patria; Stefano Ghislanzoni; Francesco Macchini; Mara Lelii; Alessandro Mori; Ernesto Leva; Nicola Principi; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2017-09-27       Impact factor: 3.390

Review 7.  The Management of Cyanotic Spells in Children with Oesophageal Atresia.

Authors:  Mathieu Bergeron; Aliza P Cohen; Robin T Cotton
Journal:  Front Pediatr       Date:  2017-05-15       Impact factor: 3.418

Review 8.  Aortopexy for the treatment of tracheomalacia in children: review of the literature.

Authors:  Michele Torre; Marcello Carlucci; Simone Speggiorin; Martin J Elliott
Journal:  Ital J Pediatr       Date:  2012-10-30       Impact factor: 2.638

9.  Posterior Tracheopexy for Severe Tracheomalacia Associated with Esophageal Atresia (EA): Primary Treatment at the Time of Initial EA Repair versus Secondary Treatment.

Authors:  Hester F Shieh; C Jason Smithers; Thomas E Hamilton; David Zurakowski; Gary A Visner; Michael A Manfredi; Christopher W Baird; Russell W Jennings
Journal:  Front Surg       Date:  2018-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.